Longer interval between neoadjuvant chemoradiotherapy and surgery is associated with improved pathological response, but does not accurately estimate survival in patients with resectable esophageal cancer

Neoadjuvant chemoradiotherapy (nCRT) has been shown to reduce tumor burden and achieve tumor regression in patients with esophageal cancer (ESC). However, the most beneficial time interval between the administration of nCRT and surgery remains unclear. Therefore, the aim of the present study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiaqi, Zeng, Xiaoxiao, Zhou, Xiaojuan, Xu, Yong, Ding, Zhenyu, Hu, Yang, Yuan, Yong, Chen, Longqi, Wang, Jin, Lu, You, Liu, Yongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018328/
https://www.ncbi.nlm.nih.gov/pubmed/36936022
http://dx.doi.org/10.3892/ol.2023.13741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018328/
https://www.ncbi.nlm.nih.gov/pubmed/36936022
http://dx.doi.org/10.3892/ol.2023.13741

Ejemplares similares